Belgium· BE-AMP-SAM250975-00
Ofloxacine EG 200 mg
A ofloxacin product containing ofloxacin, registered in Belgium by EG. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC J01MA01 (ofloxacin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC J01MA01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ofloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ofloxacin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- FR France$1.62
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ofloxacin
- Manufacturer
- EG
- Country
- Belgium (BE)
- ATC code
- J01MA01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2083004
- be_apb0775536
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
596 interactions on record for ofloxacin.
Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ofloxacin · interactions on record
596 records
- 86 severe
- 216 moderate
- 51 minor
- 170 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PrednisoloneA07EA01severe
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceMONOFLOCET 200 mg, comprimé pelliculéTAMRISA ACCESS (FRANCE)
- United StatesOFLOXACINModavar Pharmaceuticals LLC
- CzechiaOFLOXINZentiva, k.s., Praha
- NorwayOflox basicsBasics
- NetherlandsOfloxacine 200 PCH, filmomhulde tabletten 200 mgPharmachemie B.V.
- FinlandOfloxacin AlternovaAlternova Oy Ab
- PolandTarivid 200Sanofi-Aventis Deutschland GmbH
- SpainOFLOVIR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULAIndustria Quimica Y Farmaceutica Vir S.A.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3af988f0-6d7c-4f0c-9134-9e44ee260df3 GET /v1/drugs/3af988f0-6d7c-4f0c-9134-9e44ee260df3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ofloxacine EG 200 mg",
"name_fr": "Ofloxacine EG 200 mg",
"name_nl": "Ofloxacine EG 200 mg",
"amp_code": "SAM250975-00",
"strengths": [
"200.0000",
"200.0000",
"200.0000",
"80.0000",
"30.0000",
"3.0000"
],
"pack_count": 19,
"substances": [
"Ofloxacin",
"Lactose",
"Sodium Starch Glycolate (Type A)",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ofloxacin",
"authorisation_numbers": [
"BE250975"
]
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.